阿拉丁小分子抑制剂、激动剂、拮抗剂--DNA损伤/DNA修复信号通路-商家动态-资讯-生物在线
·

阿拉丁小分子抑制剂、激动剂、拮抗剂--DNA损伤/DNA修复信号通路

作者：上海阿拉丁生化科技股份有限公司 2020-11-27T09:22 (访问量:2961)

">K126884KU-55933 (ATM Kinase Inhibitor)≥98%587871-26-95mg,25mg,100mg无细胞ATM12.9 nM2.2 nMK127121KU-60019≥98%925701-49-15mg,25mg,100mg无细胞ATM6.3 nMV125220VE-821≥98%1232410-49-95mg,25mg,100mg无细胞ATR13 nM26 nMW100984Wortmannin98%19545-26-75mg,10mg,25mg无细胞PI3K3 nMDNA-PK/ATM16 nMDNA-PK/ATM150 nMT129646Torin 2≥98%1223001-51-15mg,10mg,50mgp53−/− MEFs细胞系mTOR0.25 nMPC3细胞系ATM/ATR/DNA-PK 28 nMATM/ATR/DNA-PK 35 nMATM/ATR/DNA-PK 118 nMC128014CP-466722≥98%1080622-86-15mg,25mgATM410 nME125288ETP-46464≥99%1345675-02-610mg,50mgATR25 nMC129735CGK 733≥99%905973-89-95mg,10mg,50mgATM200 nMATR200 nMA125603AZ20≥98%1233339-22-45mg,10mg,50mg无细胞ATR5 nMS117968五味子乙素分析标准品,>98%61281-37-625mg,100mgATR7.25 μMC129284磷酸氯喹≥99%50-63-55g,10g,25g,100g,500g ATM

*PARP

项目号产品名称规格CAS包装细胞靶点IC50KiEC50
O126162Olaparib (AZD2281, Ku-0059436)≥98%763113-22-010mg,25mg,100mg,250mg,1g,5gPARP15 nM
PARP21 nM
V127105Veliparib≥99%912444-00-910mg,50mg,250mg无细胞PARP15.2 nM
PARP22.9 nM
R129879Rucaparib (AG-014699,PF-01367338)≥99%459868-92-95mg,10mg,50mg PARP1.4 nM
B125751Iniparib (BSI-201)≥98%160003-66-710mg,50mg,250mg
B127705BMN 673≥98%1207456-01-610mg,50mg
A125467AG14361≥98%328543-09-55mg,10mg,50mg无细胞PARP1<5 nM
A1072073-氨基苯甲酰胺98%3544-24-91g,5g,25g,100gCHO细胞PARP<50 nM
P129886PJ34 HCl≥97%344458-15-75mg,25mg,100mg PARP 20 nM
M127627MK-4827 (Niraparib)98%1038915-60-410mg,50mg,100mgPARP1 3.8 nM
PARP22.1 nM
U129885UPF 1069≥98%1048371-03-410mg,50mgPARP18.0 μM
PARP20.3 μM
A127274AZD2461≥98%1174043-16-35mg,25mg,100mg PARP
H1571724-羟基喹唑啉≥98.0%(HPLC)491-36-15g,25g,100g
B110551苯甲酰胺99%55-21-025g,100g,500g,2.5kg PARP3.3 μM
B110552苯甲酰胺AR,98%55-21-025g,100g,500g PARP3.3 μM
B118608苯甲酰胺99.5%,升华纯化55-21-05g,25gPARP3.3 μM
P138238吡啶酰胺≥98.0%(HPLC)1452-77-35g,25g,100g　PARP95 μM　　

*DNA/RNA合成

项目号产品名称规格CAS包装细胞靶点IC50KiKd
G120180盐酸吉西他滨98%122111-03-910mg,50mg,250mg,1g,5g,25gPANC1细胞DNA合成50 nM
MIAPaCa2细胞40 nM
BxPC3细胞18 nM
Capan2细胞12 nM
P129841Pemetrexed≥99%150399-23-850mg,250mg无细胞TS1.3 nM
DHFR7.2 nM
GARFT65 nM
C110682卡铂98%41575-94-4100mg,250mg,1g,5g
P124220喷司他丁98%(HPLC)53910-25-15mg,25mg
F122998氟达拉滨98%21679-14-150mg,250mg,1g,5g
O124003奥沙利铂99%61825-94-325mg,100mg,500mg
C127663CX-5461≥98%1138549-36-65mg,25mg,100mgHCT-116细胞rRNA合成142 nM
A375细胞
MIA PaCa-2细胞
F1001495-氟尿嘧啶99%51-21-81g,5g,25g,100g,500g
C124969Capecitabine≥99%154361-50-9250mg,1g,5g,25g
F122999单磷酸氟达拉滨99%75607-67-925mg,100mg,500mg
C126447Cidofovir≥98%113852-37-225mg,100mg
C111218阿糖胞苷98%147-94-41g,5g,25g,100g
G127944Gemcitabine≥99%95058-81-450mg,100mg,250mg,1g,5g,25g
D129529Daptomycin≥98%103060-53-310mg,50mg,100mg,1g
C129833Cladribine≥98%4291-63-810mg,50mg,100mg,250mg,25gU266, RPMI8226MM1.S细胞腺苷脱氨酶2.43 μM
U266, RPMI8226MM1.S细胞0.75 μM
U266, RPMI8226MM1.S细胞0.18 μM
R129835Raltitrexed≥98%112887-68-010mg,50mg,100mg
C102625克罗拉滨99%123318-82-15mg,20mg,25mg,100mg,500mg Ribonucleotide reductase65 nM
I123381异环磷酰胺药用级3778-73-250mg,250mg,1g,5g
I123242异环磷酰胺98%3778-73-21g,5g,25g
N129848NSC 207895≥99%58131-57-01mg,5mg,10mg,50mg MDMX2.5 μM
D129847Dacarbazine≥98%4342-03-41g,5g,25g
H106352羟基脲98%127-07-11g,5g,25g,100g
F1107325-氟-2'-脱氧尿苷99%50-91-9100mg,250mg,500mg,1g,5g,25g
M1268586-巯基嘌呤 (6-MP)≥99%50-44-250mg,250mg,1g,5g,25g,100g
M129842Mizoribine≥98%50924-49-710mg,50mg,100mg,250mg
上海阿拉丁生化科技股份有限公司 商家主页

地 址： 上海市新金桥路36号财富中心16楼

联系人： 阿博士

电 话： 400-620-6333

传 真： 021-50323701

Email：market@aladdin-e.com

相关咨询

【阿拉丁】EBL-3183的工艺之路：从吲哚到临床前抑制剂 (暂无发布时间 浏览数:8322)

【阿拉丁】蛋白质印迹的上样对照 (2024-05-15T00:00 浏览数:9853)

【阿拉丁】ROS1 融合抑制剂NVL-520与MGAT2 抑制剂 BMS-963272 (2024-05-14T00:00 浏览数:9609)

【阿拉丁】胶体金在电子显微镜领域的应用 (2024-05-13T00:00 浏览数:9881)

【阿拉丁】纳米颗粒用于共振成像造影剂 (2024-05-11T00:00 浏览数:10650)

【阿拉丁】GDC-1971——SHP2抑制剂引领癌症治疗新纪元 (2024-04-28T00:00 浏览数:10577)

【阿拉丁】新药研发中的点击化学 (2024-04-25T00:00 浏览数:12681)

【限时免费！】领取阿拉丁生物产品试用装，超值体验蛋白和抗体！ (暂无发布时间 浏览数:11076)

【阿拉丁试剂】1,3-噻唑砌块在天然产物和合成材料中的应用 (2024-04-23T00:00 浏览数:12318)

【阿拉丁试剂】免疫细胞化学染色实验方案 (2024-04-22T00:00 浏览数:11910)

ADVERTISEMENT